On March 30, 2022, Alfred Altomari, the Chairman of the Board of Directors (the “ Board”) of Baudax Bio, Inc. (the “ Company”), notified the Company of his intent to resign from the Board immediately following the Company's 2022 Annual Meeting of Shareholders (the “ Annual Meeting”). On May 4, the Company held its Annual Meeting, but adjourned until May 18, 2022 at 9:00 A.M. Eastern Time to allow more time to establish a quorum. In addition, effective on May 2, 2022, the Board appointed Mr. Wayne Weisman as the Chairman of the Board.